Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate CancerWilliam Morris, Nevin Murray, Jeremy Hamm et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 736
Low-Dose-Rate Prostate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavorable Risk Prostate Cancer: The Results of the ASCENDE-RT Randomized Control TrialS. Rodda, William Morris, Scott Tyldesley et al.|International Journal of Radiation Oncology*Biology*Physics|2015Cited by 16
Low-Dose-Rate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavourable Risk Prostate Cancer: The Results of the ASCENDE-RT* Randomized Control TrialWilliam Morris, Jeremy Hamm, Scott Tyldesley et al.|Brachytherapy|2015Cited by 12
OC-0485: LDR brachytherapy is superior to 78 Gy of EBRT for unfavourable risk prostate cancer: the results of a randomized trialWilliam Morris, Jeremy Hamm, Howard Pai et al.|Radiotherapy and Oncology|2015Cited by 6